Skip to main content
Cherie-Ann Nathan, MD, Otolaryngology (ENT), Shreveport, LA

Cherie-AnnOlympiaNathanMD

Otolaryngology (ENT) Shreveport, LA

Head & Neck Oncologic Surgery, Laryngology & Voice Disorders

Jack Pou Endowed Professor & Chair of Otolaryngology-Head and neck Surgery, Louisiana State University Health Shreveport

Dr. Nathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nathan's full profile

Already have an account?

  • Office

    1501 Kings Hwy
    Shreveport, LA 71103
    Phone+1 318-675-6262
    Fax+1 318-675-6260

Summary

  • Cherie-Ann Nathan, MD, FACS, is the Pou Endowed Prof.& Chair Dept. of Otolaryngology/Head and Neck Surgery at LSU-Health Shreveport. She is also Director of Head and Neck Oncologic Surgery & Research at the Cancer Center. She completed her residency and head and neck fellowship at University of California, San Diego. She was a post-doctoral fellow at Johns Hopkins. She is a Surgeon-Scientist that maintains a busy practice treating head & neck cancer, thyroid, parathyroid, salivary gland tumors and skin cancer. The National Cancer Institute has funded her translational research since 2000 and she is recognized internationally for her seminal work on molecular analysis of surgical margins. She has pioneered multi-institutional clinical trials using mTOR inhibitors in HNSCC patients. She has also received NIH funding for chemoprevention of cancer with curcumin and her current RO1 “Targeting the FGFR-2 pathway for cutaneous SCC” holds potential for patients with aggressive cSCC. She has over 250 publications in peer-reviewed journals, and has authored multiple textbooks. She has given over 220 invited national and international lectures.
    Dr. Nathan is the current President of the Association of Academic Depts. of Oto/HNS, the Past-President of the American Head and Neck Society& Vice President for the Southern Section of the Triologic Society. She is on the Board of Directors for the American Board of Oto/HNS, American Academy of Oto/HNS, the American College of Surgeons Board of Governors & has served on the NCI Steering committee. She was awarded the Athena Award for community service and inducted into Shreveport’s 2019 Business Hall of Fame. She has been nominated as the Champion of Hope Honoree by the American Cancer Society & has a Nathan Professorship initiated by grateful patients. She received the 2020 Margaret Butler Outstanding Mentor of Women in Head & Neck Surgery and has consistently been in the Best Doctors of America.

Education & Training

  • UCSD
    UCSDMD, Head and Neck Surgery, 1994 - 1995
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1990 - 1994
  • Corewell Health – Grand Rapids/Michigan State University
    Corewell Health – Grand Rapids/Michigan State UniversityInternship, Transitional Year, 1989 - 1990
  • Topiwala National Medical College
    Topiwala National Medical CollegeClass of 1988

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 1995 - 2024
  • CA State Medical License
    CA State Medical License 1990 - 1996
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • President of American Head and Neck Society American Head and Neck Society
  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes  
    Cherie-Ann Nathan, MD, mBio

Grant Support

  • Multi-Institutional Trial: Adjuvant Mtor Targeted TherapyNational Cancer Institute2011
  • Microgranular Curcumin Biomarker Trial In Head And Neck Squamous Cell CarcinomaNational Cancer Institute2010–2011
  • Multi-Institutional Trial: Molecular Analysis Of MarginsNational Cancer Institute2005–2009
  • Molecular Analysis Of Surgical Margins With EIF4E In CanNational Cancer Institute1999–2000

Professional Memberships